PharmaVOICE - 
February 2015
Purchase Issue

In Every Issue
Letter from the Editor
The Evolution Revolution Over the past couple of years, PharmaVOICE [...]
By

Taren Grom, Editor

UpFront
Film to Shed Light on Neurological Condition       [...]
By

PharmaVOICE Staff

Innovator’s Corner
The Next-Generation Artificial Lung Patients with acute respiratory failure have [...]
By

Peter DeComo, CEO, ALung Technologies

The Network
Instagram Emerging as Pharma Friendly  Trending Now: Verified badges and [...]
By

PharmaVOICE Staff

What’s New
Dohmen Life Science Services Acquires Siren Interactive Trending now: Holistic [...]
By

PharmaVOICE Staff

Tools of the Trade
Veeva Brings User-Guided Detailing to the Cloud Trending Now: New [...]
By

PharmaVOICE Staff

Pharma Trax
Top 30 Pharma Companies R&D Spending Increases Trending Now: The [...]
By

PharmaVOICE Staff

On The Calendar
Coming Attractions PMRG’s 2015 Healthcare Marketing Researchers Connect (formerly the [...]
By

PharmaVOICE Staff

Talent Pool
Executive appointments and promotions in the healthcare industry Pharma Pool [...]
By

PharmaVOICE Staff

Last Word
Addressing the Needs of THOSE WITH RARE DISEASES Peter Saltonstall, [...]
By

Peter Saltonstall, President and CEO, National Organization for Rare Disorders (NORD)

On The Cover

Re-Imagining the Future of the Life-sciences Industry
The pharmaceutical industry — after facing dramatic changes over the past 10 years or so — has more transformative changes ahead. With an increasingly restrictive physician landscape, an ever-changing payer market, and technological advances that are speeding processes and improving data collection that result in real-world data, the industry is set to reinvent itself into [...]
By

Robin Robinson

Features

Marketing in a Digital World
As consumer use of mobile — especially smartphones — reaches critical mass, a truly integrated digital strategy is not only necessary, but positions the channel as the central port of entry for the customer experience. Back in the dawn of mobile marketing, pharma companies often viewed mobile as an add-on to their other channels, however [...]
By

Robin Robinson

A New Frontier: Bioelectronics Medicines
The nervous system is essentially the body’s electrical and communication system that wires together all the nerves and organs — starting at the brain and central cord and branching out to every other part of the body. Technological advances have led researchers to consider how the nervous system might be tapped to control organ function [...]
By

Denise Myshko

Gen Y – Gen How
Whether you want to hire them or sell them a product, meeting the needs of ­Millennials requires new strategies.   As the newest generation of healthcare consumers and employment pool, the Gen Y population — all 77 million of them — want you to know something. They want to be happy, they want to be [...]
By

Robin Robinson

Ireland: Set to Soar Again
The Irish pharmaceutical market has grown exponentially over the past 50 years thanks to a skilled talent pool, trusted environment, and good government incentives.   The Republic of Ireland, a country of about 4.7 million people, is a member of the European Union and today ranks as one of the wealthiest countries in the world [...]
By

Kim Ribbink

Innovation is Leading Cancer Research
Industry experts discuss the various avenues — immunotherapy, epigenetics, biomarkers, and other targeting technology — companies are taking to address cancer research. Great progress has been made in the fight against cancer. Advances in molecular and genomic research have unveiled complexities and changed the perception of cancer, which we now know is more than 200 [...]
By

Denise Myshko

SHOWCASE FEATURE: Outsourcing: Outsourcing in a New Era
Companies continue to examine new ways to optimize operations and capitalize on efficiencies through partnerships. As the industry continues to move to a more patient-centric model, which encompasses all aspects of the continuum from R&D through commercialization, CROs and other service partners are redefining their outsourcing models — hybrid, strategic partnership, functional, etc. — as [...]
By

Taren Grom, Editor

A New and Better Commercial Model for Enhanced Value
By combining the expertise of a CRO with that of a contract commercial organization, an outsourced provider can help clients bring business strategy to science and scientific expertise to business. Those companies able to take strategic advantage of this new model will be better positioned to focus on their strengths, bolster innovation, build value, and [...]
By

Michael Griffith, Executive VP, inVentiv Health and President, inVentiv Health Commercial

Dynamic Strategic Outsourcing and New Commercial Paradigms: Benefits of Changing The Fixed-to-variable Ratio
Biopharmaceutical companies’ commercial paradigms must respond to an ever-changing marketplace, with increasing demands from both payers and patients for better care, improved outcomes, more affordable therapies, and increased speed to market. In a recent interview, George Esgro, Vice President & Head, U.S. Commercial Sales, Quintiles, discussed how strategic outsourcing can help companies deliver the necessary [...]
By

George Esgro, Vice President & Head, U.S. Commercial Sales, Quintiles

Pharmaceutical Call Centers Build Relationships and Improve Outcomes
As communication channels expand, field-based sales representatives will be pivotal in coordinating communications with HCPs to support educational needs and ensure value is delivered no matter which channel is used. Life-sciences companies have a significant need to build relationships with healthcare providers (HCPs), patients, and caregivers. Healthcare providers are under tremendous pressure to see as [...]
By

Lou Shapiro, Senior VP, Tunstall Healthcare Group

FEEDBACK